Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt. | Cancelled | 6 | - |
| 2 | Schedule 2 | Not yet disclosed by govt. | Cancelled | 6 | - |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
29 Jan 2024, 12:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Nepafenac ophthalmic solution susp 0.1% Nevanac 5ml Bott of eye drop (Q3)
Ranolazine 500mg Tab (Q3)
5795871
GEM/2023/B/4392021
Two Packet Bid
Nepafenac ophthalmic solution susp 0.1% Nevanac 5ml Bott of eye drop,Ranolazine 500mg Tab
15 days
Delhi; New Delhi
Item wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
₹31
60%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Nepafenac ophthalmic solution susp 0.1% Nevanac 5ml Bott of eye drop (Q3) | NEW DELHI | 2,470 | 15 days | - |
| Ranolazine 500mg Tab (Q3) | NEW DELHI | 20,100 | 15 days |
Exempted
29 Jan 2024
26 Dec 2023
29 Jan 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5795871.pdf
GEM_BID
reechs67_2023-12-25-11-27-12_bac038007bc02eb713e3acbbc958a915.pdf
SPECIFICATION
reechs67_2023-12-25-11-31-19_a06a4dbdde8884feafd43138ce84c27b.pdf
SPECIFICATION
REECHS67_89030e6e-f3fd-4180-a1951703484341798_soharabmudgil.500a@gov.in.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .